Oruka Corp - ORKA Net earnings per share for the last four quarters

Oruka Pharma (ORKA) - corporate logo

The annual EPS TTM trend for Oruka Therapeutics Inc (ORKA) demonstrates current patterns, where the parameter value equals -2.40. The startup's environmental policy is formal in nature and limited to office management. Business prospects depend on the efficacy of new psoriasis molecules and liquidity reserves. The team is attracting leading dermatologists by offering an innovative environment and lucrative stock option programs.

ORKA: Oruka Corp Earnings per share for the last twelve months 11/23/2025 - 11/18/2026

Financial and market metric breakdowns for Oruka Pharma (ORKA)

- current quotes and average value forecast:
Initial company analysis:ORKA - Oruka Therapeutics
Product sample of Oruka Corp

For the young biotechnology company Oruka Therapeutics Inc (ORKA), this indicator reflects capital management efficiency through net earnings per share dynamics. The metric measures the percentage deviation of the current total annual EPS from the same period last year, accounting for the market discounting of flows. Analyzing the YoY EPS change on a rolling 12-month basis allows for an assessment of business scaling rates supported by specialized funds.